Insider Transactions Reported by 21 Insiders of BridgeBio Pharma, Inc.

Symbol
BBIO on Nasdaq
Location
Palo Alto, CA

Insiders trading volume in the past year

BridgeBio Pharma, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
VIKING GLOBAL INVESTORS LP 10%+ Owner $816,436,500 -$260,989,998 -24% 27 Jun 2025
KKR Genetic Disorder L.P. 10%+ Owner $453,525,208 -$402,960,000 -47% 12 May 2025
Neil Kumar Chief Executive Officer, Director $385,182,179 -$65,913,672 -15% 12 Dec 2025
FRANK MCCORMICK Director $51,404,193 -$21,669,537 -30% 29 Oct 2025
CHARLES J. HOMCY Director $44,000,352 -$13,912,443 -24% 08 Aug 2025
Thomas Trimarchi President and CFO $27,730,650 -$4,087,208 -13% 12 Dec 2025
Maricel Apuli Chief Accounting Officer $9,641,294 -$233,469 -2.4% 12 Dec 2025
BRIAN C. STEPHENSON CFO and Treasurer $6,443,801 -$2,899,849 -31% 25 Feb 2025
Ali J. Satvat Director $5,451,210 20 Jun 2025
Andrew Lo Director $4,285,707 -$10,169,562 -70% 17 Nov 2025
JAMES C. MOMTAZEE Director $3,122,427 20 Jun 2025
RICHARD H. SCHELLER Director $2,421,359 16 Feb 2023
DANIELS RONALD J Director $1,082,695 -$3,888,999 -78% 06 Nov 2025
Randal W. Scott Director $1,041,677 -$666,465 -39% 17 Nov 2025
Andrea Ellis Director $910,861 -$2,212,683 -71% 05 Aug 2025
Douglas A. Dachille Director $873,182 20 Jun 2025
Fred Hassan Director $850,194 20 Jun 2025
Hannah Valantine Director $513,884 -$2,482,235 -83% 12 Nov 2025
Jennifer Cook Director $451,254 20 Jun 2025
ERIC AGUIAR Director $216,382 20 Jun 2025
BRENT L. SAUNDERS Director 22 Jun 2022

Recent Insider Transactions by Companies or Individuals for BridgeBio Pharma, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.